Join to View Full Profile
1665 Aurora CtAurora, CO 80045
Phone+1 720-848-0000
Fax+1 303-493-7000
Dr. Asgari is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
University of Texas Southwestern Medical CenterFellowship, Micrographic Surgery and Dermatologic Oncology, 2004 - 2005
University of WashingtonResidency, Dermatology, 1999 - 2002
Beth Israel Deaconess Medical CenterInternship, Internal Medicine, 1998 - 1999
Yale School of MedicineClass of 1997
Certifications & Licensure
CO State Medical License 2023 - 2027
CA State Medical License 2003 - 2026
MA State Medical License 2014 - 2023
American Board of Dermatology Dermatology
Awards, Honors, & Recognition
- Fellow (FAAD) American Academy of Dermatology
Publications & Presentations
PubMed
- Clinicopathologic Attributes and Downstream Outcomes of Mucosal Melanomas: A Multi-Hospital Cohort Study.Sara Khattab, Emma Beagles, Matthew Tran, Cameron Moseley, Guihong Wan
Journal of the American Academy of Dermatology. 2025-03-28 - Understanding patient perspectives on vaccine decision making in adults with autoimmune bullous diseases: a qualitative study.Alice J Tan, Marjorie Archila, John S Barbieri, Arash Mostaghimi, Aaron M Scherer
Archives of Dermatological Research. 2024-04-18 - 10 citationsGlobal epidemiology of actinic keratosis in the general population: a systematic review and meta-analysis.Christopher D George, Truelian Lee, Loes M Hollestein, Maryam M Asgari, Tamar Nijsten
The British Journal of Dermatology. 2024-03-15
Journal Articles
- Association Between Topical Calcineurin Inhibitor Use and Keratinocyte Carcinoma Risk Among Adults with Atopic DermatitisMaryam Asgari, MD, JAMA Dermatology
- Multiple Basal Cell Carcinomas in a Patient with Myotonic Dystrophy Type 1Jessica Feng, Maryam M Asgari, Emergency Medicine Journal
Authored Content
- Association Between Topical Calcineurin Inhibitor Use and Keratinocyte Carcinoma Risk Among Adults with Atopic DermatitisAugust 2020
Press Mentions
USPSTF Issues Updated Recommendations on Skin Cancer ScreeningApril 18th, 2023- USPSTF: Evidence for Skin Cancer Screening Is InadequateApril 18th, 2023
- USPSTF Releases Updated Recommendations on Skin Cancer ScreeningApril 18th, 2023
- Join now to see all
Grant Support
- Patient oriented research and mentoring program in dermatologic diseasesUNIVERSITY OF COLORADO DENVER2023–2026
- The Role of Genetic Risk Factors in Keratinocyte Carcinoma SusceptibilityKAISER FOUNDATION RESEARCH INSTITUTE2020–2026
- The Role of Genetic Risk Factors in Keratinocyte Carcinoma SusceptibilityKAISER FOUNDATION RESEARCH INSTITUTE2020–2026
- Training in Translational Research of Skin DiseasesUNIVERSITY OF COLORADO DENVER1981–2026
- PQ3 Cutaneous squamous cell carcinoma: Integrating germline and somatic alterations that underlie tumor progressionUNIVERSITY OF COLORADO DENVER2019–2025
- Nsaid Use In Chemoprevention Of Squamous Cell CarcinomasNational Institute Of Arthritis And Musculoskeletal And Skin Diseases2005–2009
- The Role Of HPV In Squamous Cell CarcinomaNational Institute Of Arthritis And Musculoskeletal And Skin Diseases2000–2002
Professional Memberships
- Fellow
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
